← FDA Drug Approvals (Drugs@FDA)
FLUTICASONE PROPIONATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK SPECLT · Approved 2026-03-16
Drug application
- FDA Application #
ANDA218742- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- FLUTICASONE PROPIONATE
- Generic name
- FLUTICASONE PROPIONATE
- Active ingredients
- FLUTICASONE PROPIONATE
- Dosage form
- SPRAY, METERED
- Route
- NASAL
- Marketing status
- Over-the-counter
- Sponsor
- GLENMARK SPECLT
- Manufacturer
- GLENMARK THERAPEUTICS INC., USA
- First approval
- 2026-03-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown